The Irish Cancer Society was the only Patient Advocacy Group from Ireland selected to present its innovative patient partnership model at ASCO 2026, the world’s largest oncology conference.
MSD has announced European Commission approval for ENFLONSIA™ (clesrovimab) for the prevention of RSV lower respiratory tract disease in newborns and infants during their first RSV season.
The Government has finalised new framework agreements with Medicines for Ireland and the Irish Pharmaceutical Healthcare Association to improve access to medicines and strengthen supply security.
Johnson & Johnson has announced European approval for eligible multiple myeloma patients or caregivers to self-administer DARZALEX® from the fifth dose onwards.
